NVS Novartis AG

Updated 08 Nov 2026 14:45. Information, not advice.

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

• Novartis shelves potential blockbuster pelacarsen as landmark study fails (opens in a new tab) Investing.com · 07 Nov 2026 15:46
• Update: Market Chatter: Novartis Reports Two Confirmed Tumor Cases Linked to Neuromuscular Gene Therapy (opens in a new tab) MT Newswires · 06 Nov 2026 10:48
• $1000 Invested In Novartis 5 Years Ago Would Be Worth This Much Today (opens in a new tab) Benzinga · 05 Nov 2026 19:15
• Novartis: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 04 Nov 2026 01:47
• BioArctic collaborator Novartis terminates agreement (opens in a new tab) 02 Nov 2026 21:36
• BioArctic AB Announces Novartis Terminates Their 2025 Option, Collaboration And License Deal; BioArctic To Retain Full $30M Upfront Payment (opens in a new tab) Benzinga · 02 Nov 2026 17:49
• Deutsche Bank turns bearish on Novartis as shares recover failed trial losses (opens in a new tab) Investing.com · 02 Nov 2026 10:16
• Allarity Therapeutics Settles $4.9M Novartis Liability For $1M Payment (opens in a new tab) Benzinga · 02 Nov 2026 09:06
• Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial (opens in a new tab) Simply Wall St. · 02 Nov 2026 01:07

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.